Advanced Search

 

Study ID Status Title Patient Level Data
JNAI-04 Completed A Placebo-Controlled Study to Evaluate the Efficacy and Safety of Zanamivir 10 mg administered Twice Daily (20 mg/day) or 20 mg Twice Daily (40 mg/day) for 5 Days in the Treatment of Influenza A and B Viral Infections, and to Assess the Presence or Absence of Dose-Response Relationship of Zanamivir
JNAI-07 Completed A Double -Blind, Placebo-Controlled Study to Investigate the Therapeutic Effect and Safety of Zanamivir 10 mg Administered Twice Daily (20 mg/day) or 20 mg Administered Twice Daily (40 mg/day) for Five Days in the Treatment of Influenza A and B Infections
KGW111083 Completed A double-blind, randomized, 6-sequence, 3-period, crossover drug drug interaction study to evaluate the pharmacokinetics of Wellbutrin SR and GSK189075 when co-administered or administered alone in healthy male volunteers
L8518 Completed Flexibility in administration of Arixtra for prevention of symptomatic venous thromboembolism in orthopedic surgery
LAM100034 Completed A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Partial Seizures Study Listed on ClinicalStudyDataRequest.com
LAM100036 Completed A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures Study Listed on ClinicalStudyDataRequest.com
LAM10004 Completed An open, randomised, parallel group study in healthy, young, male and female volunteers to evaluate the pharmacokinetic characteristics of single oral does of new LAMICTALâ„¢ formulations. Study Listed on ClinicalStudyDataRequest.com
LAM10005 Completed A two-part, open label study in healthy, young, male and female volunteers to evaluate the pharmacokinetic characteristics of single and repeat oral doses of Lamictal SR/XR prototype formulations and to study the effects of food on pharmacokinetic parameters. Study Listed on ClinicalStudyDataRequest.com
LAM100118 Completed Evaluation of lamotrigine in subjects with absence seizures Study Listed on ClinicalStudyDataRequest.com
LAM10016 Completed An open-label, non-randomised, single-sequence study to investigate the effects of the combined oral contraceptive pill on the pharmacokinetics of lamotrigine and the effects of lamotrigine on the pharamcokinetics of the combined oral contraceptive pill in healthy young female subjects. Study Listed on ClinicalStudyDataRequest.com
LAM10017 Completed An open-label study in healthy male and female volunteers to evaluate the repeat dose pharmacokinetics and dose strength equivalence of lamotrigine enteric coated modified release tablets over the dose range 25-200 mg. Study Listed on ClinicalStudyDataRequest.com
LAM105379 Completed A pivotal single-dose randomised, parallel-group, open-label study to demonstrate bioequivalence of 300mg lamotrigine XR relative to 100mg + 200mg lamotrigine XR and to demonstrate lack of food effect on 300mg lamotrigine XR in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com
LAM20006 Completed A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 months) Study Listed on ClinicalStudyDataRequest.com
LAM20007 Completed An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive subjects (1-24 months of age) Study Listed on ClinicalStudyDataRequest.com
LAM30007 Completed Open-Label, Multicenter, Randomized Trial to Evaluate the Development of Components of Polycystic Ovary Syndrome (PCOS) in Female Subjects Initiating Lamotrigine or Valproate Either as Monotherapy for Newly Diagnosed Epilepsy or as Adjunctive Therapy for Inadequately Controlled Epilepsy Study Listed on ClinicalStudyDataRequest.com
LAM30055 Completed A Multicenter, Double-Blind, Randomized Conversion to Monotherapy Comparison of Two Doses of Lamotrigine for the Treatment of Partial Seizures Study Listed on ClinicalStudyDataRequest.com
LAM40006 Completed A Multicenter, Double-Blind, Randomized, Placebo-Controlled Evaluation of LAMICTAL (lamotrigine) in Adult Subjects with HIV-Associated Peripheral Neuropathy Study Listed on ClinicalStudyDataRequest.com
LAM40013 Completed A Multicenter, Open-Label Conversion of Valproate Monotherapy to Lamotrigine Monotherapy in Patients with Epilepsy Study Listed on ClinicalStudyDataRequest.com
LAM40091 Completed Lamictal in Combination with Newer and Older Antiepileptic Drugs and as Monotherapy: A Practical Clinical Assessment of Tolerability and Clinical Effectiveness (The TARGET Study: Trial to Assess and Refine Global Epilepsy Treatment) Study Listed on ClinicalStudyDataRequest.com
LAM40097 Completed A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects wtih Primary Generalized Tonic-Clonic Seizures Study Listed on ClinicalStudyDataRequest.com
LAM40112 Completed Double-blind Randomized Trial of Cognitive Effects of LAMICTAL (LAMOTRIGINE) versus Topiramate in Epilepsy Study Listed on ClinicalStudyDataRequest.com
LAM40117 Completed A Multicenter, Open-Label, Pilot study of Lamotrigine as Adjunctive Therapy and Monotherapy in Patients with Epilepsy and Comorbid Depressive Symptoms Study Listed on ClinicalStudyDataRequest.com
LAM40124 Completed An Assessment of Behavioral Changes Associated with Lamotrigine and Levetiracetam in Patients with Epilepsy Study Listed on ClinicalStudyDataRequest.com
LBI108614 Completed An open-label, randomised, single-dose, parallel-group study to evaluate the pharmacokinetic characteristics, safety and tolerability of up to two formulations (with different taste masking approaches) of an orally disintegrating tablet (ODT) of lamotrigine at 25mg and 200mg versus the immediate release (IR) lamotrigine in healthy subjects Study Listed on ClinicalStudyDataRequest.com
LBI108617 Completed An open-label, randomised, single-dose, parallel-group study to demonstrate bioequivalence of two formulations and the effect of food and water on one formulation of lamotrigine in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.